fasudil has been researched along with Hypercapnia in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Hypercapnia: A clinical manifestation of abnormal increase in the amount of carbon dioxide in arterial blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kidoguchi, K | 1 |
| Tamaki, M | 1 |
| Mizobe, T | 1 |
| Koyama, J | 1 |
| Kondoh, T | 1 |
| Kohmura, E | 1 |
| Sakurai, T | 1 |
| Yokono, K | 1 |
| Umetani, K | 1 |
1 other study available for fasudil and Hypercapnia
| Article | Year |
|---|---|
In vivo X-ray angiography in the mouse brain using synchrotron radiation.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Animals; Carotid Arteries; Ca | 2006 |